Rallybio Corporation

RLYB | NASDAQ

Price Alert Chart Builder DCF Calculator

$16.97

+$0.04 (+0.24%)

Sep 22, 2026, 11:35 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $89.85M

Enterprise Value $-3M

Beta -0.85

Average Volume 69.68K

Shares Outstanding (Diluted) 5.8M

Shares Change YoY 3.44%

Institutional Ownership 82.03%

Exchange NASDAQ

ISIN US75120L2097

Price Performance

Price Change 1M 1.2%

Price Change 3M 7.8%

Price Change 6M 96.2%

Price Change YTD 199.1%

Price Change 1Y 247.6%

Price Change 3Y -56.5%

Price Change 5Y -84.8%

1M CAGR (ann.) 4.8%

1Y CAGR (ann.) 253.4%

5Y CAGR (ann.) -28.5%

All-Time CAGR -30.8%

Valuation

PE Ratio 2.17

Forward PE N/A

PEG Ratio 0.00

Forward PEG 0.02

PS Ratio 139.08

Forward PS 1.00

PB Ratio 0.95

P/FCF Ratio 3.41

P/Adj. FCF Ratio 3.83

P/OCF Ratio 3.66

EV/Sales -4.65

EV/EBIT -0.11

EV/EBITDA -0.11

EV/FCF -0.11

Earnings Yield 46.1%

FCF Yield 29.3%

Adj. FCF Yield 26.1%

Financial Health

Net Cash $92.85M

Total Debt $0

Cash & Short-Term Investments $92.85M

Total Assets $98.06M

Current Ratio 27.26

Quick Ratio 27.26

Debt / Equity Ratio 0.00

Debt / EBITDA 0.00

Debt / FCF 0.00

OCF / Debt N/A

Interest Coverage 0.00

Altman Z-Score 13.37

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin -1107.6%

Operating Profit Margin -3672.3%

EBITDA Margin 4174.1%

Net Profit Margin 7051.2%

FCF Margin 4077.4%

Adj. FCF Margin 3635.0%

SBC / Revenue 442.4%

SBC Impact (per share) -10.8%

Returns

Return on Assets 46.5%

Return on Equity 68.6%

Return on Invested Capital -24.4%

Return on Capital Employed -25.1%

Return on Tangible Assets 46.5%

Historical Growth (CAGR)

Revenue CAGR 3Y 30.5%

Revenue CAGR 5Y 60.2%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 236.3%

EPS CAGR 5Y 59.9%

EPS CAGR 10Y N/A

FCF CAGR 3Y 173.0%

FCF CAGR 5Y 47.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Hold

Analyst Count 0

EPS Growth Next 3Y -20.9%

Revenue Growth Next 3Y 416.5%

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$1.44

EPS Growth Est (next Q) -49.3%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number $53.94

Graham Upside 218.6%

Lynch Fair Value $195

Lynch Upside 1051.8%

Price Target N/A

Price Target Upside N/A

Cash Flow

Operating Cash Flow $26.34M

Free Cash Flow $26.34M

Adj. Free Cash Flow $23.48M

FCF Per Share $4.62

OCF Per Share $4.62

OCF/S Ratio 4077.4%

Income Statement

Revenue $646K

Gross Profit $-7.16M

Operating Income $-23.72M

EBITDA $26.97M

Net Income $45.55M

EPS (Diluted) $7.80

Revenue / Employee $92.29K

Profit / Employee $6.51M

Employees 7